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Compliancecompliance of HSIL patients to the national Dutch routine follow-up protocol in
the ﬁrst 2 years after LLETZ and to determine if based on the status of excision margins, follow-up intervals
could be modiﬁed.
Methods. A prospective cohort study was performed in patients, referred because of an abnormal Pap
smear between 1996 and 2004 and treated for HSIL with LLETZ. The Dutch national routine follow-up
protocol orders a Pap smear after 6, 12 and 24 months, respectively. Follow-up results were completed by
using PALGA, the nationwide network and registry of histo- and cytopathology in the Netherlands. To assess
compliance to the follow-up protocol, adequate follow-up was deﬁned as three cervical smears taken after 6
(+/−3), 12 (+/−3) and 24 (+/−3) months, respectively.
Results. Compliance to the ﬁrst 2 years follow-up protocol declined from 86.2% to 64.8% to 51.2% for ﬁrst,
second and third follow-up cervical smears, respectively. Patients with involved excision margins had a three
times higher overall risk of developing a subsequent HSIL after LLETZ as compared to patients with free
excision margins (HR: 3.2, 95% CI=1.3–7.9, p=0.01). Risk for diagnosing HSIL during the ﬁrst 12 months of
follow-up for patients with free excision margins was only 1%.
Conclusions. Compliance to the Dutch national routine follow-up protocol in HSIL patients after LLETZ is
only moderate. For HSIL patients with free excision margins after LLETZ the ﬁrst cytological follow-up
interval can safely be increased to 12 months.
© 2008 Elsevier Inc. All rights reserved.Introduction
Cytological examination of the cervix enables identiﬁcation of
asymptomatic precursor lesions of cervical cancer, so-called squa-
mous intraepithelial lesions (SILs). Widespread introduction of
population-based screening programs for these precursor lesions in
developed countries contributed to a lower mortality and morbidity
rate for cervical cancer. However, especially due to absence of
population-based screening programs in many low-income countries
the incidence of cervical cancer in 2002 was still 493,000 cases with a
mortality rate of 273,000 women worldwide in 2002 [1].
Progression to cervical cancer of pre-malignant lesions is
estimated to be 1% for low-grade SILs (LSILs) and up to 50% for
high-grade SILs (HSILs) [2,3]. Therefore, many clinicians feelan der Zee).
ll rights reserved.compelled to treat patients with HSILs, while patients with LSILs
are often followed up. Different techniques have been developed for
treatment of HSILs and these are all equally effective [4–6].
Nowadays treatment of choice for HSILs is a Large Loop Excision of
the Transformation Zone (LLETZ). Advantages of this method are the
simplicity of the procedure and the production of a specimen for
histological diagnosis, thereby allowing assessment of the excision
margins [7]. Using therapy in an outpatient setting to treat HSIL
reduces the risk of cervical cancer by 95% in the ﬁrst 8 years after
therapy [8]. However, the risk of cervical cancer, even with a careful
long-term follow-up scheme, remains ﬁve times greater for these
patients as compared to the general population [9]. For that reason,
after initial treatment with LLETZ patients usually are followed up at
different intervals by cervical smear and/or colposcopy for early
detection of a subsequent SIL. Many different protocols at different
intervals for follow-up after LLETZ have been used and to our
knowledge no data are available on compliance. After incomplete
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SIL is higher when compared to complete excision [10].
After treatment of HSIL, the current Dutch national guideline for
follow-up includes a cervical smear at 6,12 and 24months after LLETZ.
In case of no subsequent SIL during this 24months follow-up, patients
will return to the population-based screening program (one cervical
smear every 5 years for women between 30–60 years), performed by
general practitioners. Aims of the present study were to assess the
compliance of our HSIL patients to the national Dutch routine follow-
up protocol in the ﬁrst 2 years after LLETZ and to determine if, based
on the status of excision margins, follow-up intervals in the ﬁrst
2 years could be modiﬁed.
Patients and methods
Patients
A prospective cohort study was performed in patients who were
referred because of an abnormal Pap smear to the outpatient clinic of
the Department of Obstetrics and Gynecology of the University
Medical Center Groningen (UMCG), The Netherlands between 1996
and 2004. During this time period, patients were asked to participate
in various studies on new biomarkers in cervical neoplasia. In light of
these studies information on data, diagnoses and treatment details
were prospectively collected in separate databases after retrieval
from the electronic patient ﬁles. For the present study only
anonymised data from patients who had given written informed
consent to participate in the previously mentioned studies, which
were all approved by the Institutional Review Board (IRB) from the
UMCG, were used.
Diagnostic work-up and treatment protocol
Patients with a Pap 2 (atypical cells) or Pap 3A (mild/moderate
dysplasia) cervical smear ﬁrst underwent colposcopy and biopsy.
Histological diagnosis of HSIL after biopsy was followed by LLETZ.
Patients referred to the outpatient clinic with a Pap 3B (severe
dysplasia) cervical smear or higher, without suspicion of cervical
cancer, underwent colposcopy and LLETZ in the same session. After
LLETZ the routine follow-up of patients consists of a cervical smear at
6, 12 and 24months, taken by a gynecologist at the outpatient clinic of
the UMCG. In case of no subsequent SIL, patients returned to the
population based screening program, which implies one cervical
smear by the general practitioner every 5 years for women between
30 and 60 years. This protocol is in accordance with national Dutch
guidelines for follow-up after LLETZ since 1996. In case of an abnormal
cervical smear during follow-up the patient was scheduled for
colposcopy and biopsy or re-LLETZ.
Histological examination of all specimens was performed by an
experienced gynecologic pathologist (HH). Since 1996 the statuses of
the endocervical and ectocervical excision margins of a LLETZ are
examined systematically. Excision margins were labeled as positive
when endocervical and/or ectocervical margins showed dysplasia.Table 1
Compliance to follow-up protocol.
Category First cervical smear Category S
Eligible 515 5
Censoreda 0
b3 months 6 (1.2%) b9 months
3–9 months 444 (86.2%) 9–15 months 2
N9 months 65 (12.6%) N15 months 1
Total 515 (100%) Total 4
a Censored: patients after ﬁrst and second follow-ups with no cervical smear, with an abSelection criteria
Between January 1996 and December 2004, 808 patients visited
our outpatient clinic because of abnormal Pap smear. For the present
study we selected 520 patients, who underwent LLETZ for HSIL, from
the database. Median follow-up of the study population was
53 months with a minimum of 6 months and a maximum of
131 months.
Follow-up data collection
PALGA, the nationwide network and registry of histo- and
cytopathology in the Netherlands, was used to complete follow-up
information regarding the results of cervical smears during follow-up.
For all patients, all cytological and histological follow-up information
on date, kind of treatment and results were collected. Follow-up data
were collected till March 2007.
Statistical analysis
For data collection and analysis, the software system of SPSS
software package was used (SPSS 14.0, Chicago, IL, USA). To assess
compliance to the follow-up protocol, we deﬁned complete follow-up
as cervical smears taken after 6 (+/−3), 12 (+/−3) and 24 (+/−3)
months, respectively. Analysis for compliance to the follow-up
protocol at the different time points in the ﬁrst 2 years was only
performed for those patients in whom a complete follow-up protocol
was still possible, i.e. patients who did not have a second smear were
censored for the analysis at the third time point. In addition, patients
with an abnormal or not to judge Pap smear during follow-up and
patients who underwent a hysterectomy for other reasons were
censored. The time from the LLETZ to the incidence of SIL in follow-up
was assessed for patients with free excision margins as compared to
patients with margins not free of dysplasia, by using a Kaplan Meier
model. Differences were tested by using a log-rank test. In addition,
Cox regression analyses were performed to estimate the impact of
excision margins on the incidence of SIL and HSIL. To estimate the
overall probability of SIL occurring at different time points, life-tables
were constructed. Statistical signiﬁcance was assumed if the p value
was b0.05.
Results
Any cytological follow-upwas performed in 515/520 (99%) eligible
HSIL patients who underwent LLETZ. Compliance to the follow-up
protocol declined from 86.2% to 64.8% to 51.2% for ﬁrst, second and
third cervical smears, respectively (Table 1). Therefore, only 51.2% of
the HSIL patients treated with LLETZ completed the total follow-up
program in the ﬁrst 2 years.
An abnormal Pap smear (Pap 2 N) during overall follow-up
was found in 62/515 (12.0%) patients. Histological follow-up
specimens were available from biopsies, LLETZ and hysterectomies
(also for non-cervical neoplasia reasons) for 83/515 (16.1%) patients.econd cervical smear Category Third cervical smear
15 455
60 72
22 (4.8%) b21 months 44 (11.5%)
95 (64.8%) 21–27 months 196 (51.2%)
38 (30.3%) N27 months 143 (37.3%)
55 (100%) Total 383 (100%)
normal or not to judge cervical smear or a hysterectomy.
Fig. 1. Time (in years) to subsequent SIL (LSIL or N) based on the status of excision
margins. Time to subsequent SIL (LSIL or N) was estimated by the Kaplan–Meier method
and evaluated by log-rank test.
Fig. 2. Time (in years) to subsequent HSIL based on the status of excision margins. Time
to subsequent HSIL was estimated by the Kaplan–Meier method and evaluated by log-
rank test.
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not available, 42 (8.2%) no dysplasia, 13 (2.5%) LSIL and 22 (4.2%)
HSIL. In 35/515 (6.8%) patients subsequent SILs were diagnosed; 24/
35 (68.6%) during the ﬁrst 2 years of follow-up and 11/35 (31.4%)
after 2 years follow-up. During the ﬁrst 2 years of follow-up 12/22
(54.5%) HSILs were diagnosed and after 2 years 10/22 (45.5%). For
patients with an abnormal Pap smear during follow-up (n=62),
histological specimens were obtained from 41 (66%) patients.
Histological diagnosis of these specimens was: 14 no dysplasia,
9 LSIL and 18 HSIL.
Excision margins were free of dysplasia in 315 (61.2%) patients, not
free of dysplasia in 101 (19.6%) patients and difﬁcult to determine or
not mentioned in 99 (19.2%) patients. As a result 416 patients were
available for the analysis of the association between excision margins
and subsequent SIL. Fig. 1 shows the occurrence of subsequent SIL in
relation to the status of the excision margins. In 315 patients with free
excision margins 17 (5.4%) subsequent SILs were diagnosed as
compared to 11 (10.9%) subsequent SILs in 101 patients with involved
excision margins (log-rank test, p=0.017). Patients with involved
excision margins therefore had more than two times higher chance of
developing a subsequent SIL compared to patients with free excision
margins (HR: 2.5, 95% CI=1.1–5.3, p=0.021).
In patients with free excision margins and subsequent SILs
(n=17), 6 patients were diagnosed with LSIL and 11 patients were
diagnosed with HSIL. In patients with involved excision margins and
subsequent SIL (n=11), 2 patients were diagnosed with LSIL and 9
patients were diagnosed with HSIL. In Fig. 2 subsequent HSIL for free
excision margins, 3.5% (11/315), is compared with subsequent HSIL
for involved excision margins, 8.9% (9/101) (log-rank test, p=0.006).
Patients with involved excision margins had a three times higher
chance of developing subsequent HSIL compared to patients with free
excision margins (HR: 3.2, 95% CI=1.3–7.9, p=0.01).
Table 2 shows inmore detail the risk of detecting SIL during follow-
up. The overall risk for HSIL was 0% after ﬁrst 6 months, 2% after 1 year
and 1% after 2 years. The overall risk for SIL was 1% after ﬁrst 6months,
3% after 1 year and 2% after 2 years. If we only consider patients with
free excision margins, the overall risk for HSIL is even lower, 0% after
6 months, 1% after 1 year and 1% after 2 years. In patients with
involved excision margins the overall risk is 2% after 6 months, 6%
after 1 year and 1% after 2 years.Discussion
Our study indicates that patients diagnosedwith HSIL, treatedwith
LLETZ and free excision margins have a negligible risk (1%) for
detection of HSIL during the ﬁrst 12 months of follow-up. Therefore,
for HSIL patients after LLETZ with free excision margins the ﬁrst
follow-up visit might be postponed until 12 months after treatment.
Recently a meta-analysis by Ghaem-Maghami et al. showed a
pooled prevalence of overall 22% post-treatment cervical dysplasia
(deﬁned as abnormal cytology or histology) for patients treated with
loop diathermy and involved excision margins [10]. The lower
prevalence of post treatment cervical dysplasia (6.8%) in our study
compared to this meta-analysis is probably due to the deﬁnition of
post-treatment disease, which was deﬁned as histological proven LSIL
or higher in our study. Another explanation could be that in our
hospital management of patients with abnormal Pap smears is
centralized at the Cervical Dysplasia Outpatient Clinic. All patients
are treated by a small group of medical doctors, specialized in
colposcopy and LLETZ, using a standardized treatment protocol over
years. Ghaem-Maghami et al. recommended that patients with
incomplete excision margins need close follow-up for at least
10 years and some patients may beneﬁt from an immediate second
treatment [10]. Several other studies suggested to follow-up patients
with incomplete excision more intensively by colposcopy and/or
cytology, because of an increased risk of subsequent dysplasia [11–14].
Our study however again illustrates that the far majority of patients
with incomplete excision do not develop HSIL, so intensive follow-up
will result in a possible beneﬁt for only a very small number of these
patients.
Persistent post-treatment high-risk human papillomavirus (hr-
HPV) is a risk factor for subsequent SIL [15,16]. A meta-analysis of
Zielinski et al. showed that the status of excision margins, post-
treatment cytology, post-treatment hr-HPV or combinations had a
negative predictive value of 91–99%, the positive predictive values of
these parameters were 25–51% [17]. Based on this study they
proposed to follow-up patients with negative cytology in combination
with negative hr-HPV DNA testing less intensively. Still the need for a
marker with a higher positive predictive value remains, which allows
more individually modiﬁcation of follow-up protocols.
The effectiveness of a follow-up protocol is limited by the
compliance to the protocol by both medical doctor and patient. In
our study compliance to the follow-up protocol in the ﬁrst 2 years
Table 2










Time point SIL HSIL Free Not free Free Not free
6 months 1% 0% 0% 2% 0% 2%
12 months 3% 2% 2% 7% 1% 6%
24 months 2% 1% 2% 1% 1% 1%
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compliance to the follow-up protocol after LLETZ. An explanation for
the moderate compliance that we observed could be that the
simplicity of the LLETZ procedure in an outpatient setting, may give
to patients the idea that their condition is less severe and therefore
needs less follow-up care [18]. Another explanation might be that
anxious women are less likely to attend for a repeat cervical smear
within the recommended time frame [19]. If the last explanation is
true, anxiety for follow-up visits should be decreased by face-to-face
education and supportive care after colposcopy [20]. Although our
follow-upwasmainly performed by the samemedical doctorwho also
performed the LLETZ, compliance was still disappointing. With the
current decreasing compliance over time, it might bemore effective to
bypass the ﬁrst follow-up visit after 6 months and focus on increasing
compliance 1 year after LLETZ. Furthermore, the need for long-term
follow-up should be emphasized, because due to the weak perfor-
mance of the Pap smear [21] in combination with moderate
compliance to the follow-up protocol and the fact that almost half of
the subsequent HSILs (45.5%) are diagnosed after the ﬁrst 2 years of
the routine follow-up protocol, the risk of developing cervical cancer
for HSIL patients after LLETZ is still present.
In conclusion, our study in a large, well documented series of
patients indicates that compliance to the Dutch national routine
follow-up protocol in HSIL patients after LLETZ is only moderate. For
HSIL patients treated with LLETZ and free excision margins ﬁrst
follow-up interval might safely be increased to 12 months.
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